119 related articles for article (PubMed ID: 37209999)
1. First cocrystal of esculetin: Simultaneously optimized in vitro/vivo properties and antioxidant effect.
Liu F; Li JY; Han CB; Wang JH; Tong SY; Wang XK; Li YT; Sun WJ
Eur J Pharm Sci; 2023 Aug; 187():106469. PubMed ID: 37209999
[TBL] [Abstract][Full Text] [Related]
2. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA
Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223
[TBL] [Abstract][Full Text] [Related]
4. Emodin-nicotinamide (1:2) cocrystal identified by thermal screening to improve emodin solubility.
Park B; Yoon W; Yun J; Ban E; Yun H; Kim A
Int J Pharm; 2019 Feb; 557():26-35. PubMed ID: 30572078
[TBL] [Abstract][Full Text] [Related]
5. Cocrystal of phloretin with isoniazid: preparation, characterization, and evaluation.
Lu Z; Chen H; Mo J; Yuan X; Wang D; Zheng X; Zhu W
RSC Adv; 2023 Apr; 13(16):10914-10922. PubMed ID: 37033443
[TBL] [Abstract][Full Text] [Related]
6. Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.
Huang Y; Zhang B; Gao Y; Zhang J; Shi L
J Pharm Sci; 2014 Aug; 103(8):2330-7. PubMed ID: 24903146
[TBL] [Abstract][Full Text] [Related]
7. Glibenclamide-malonic acid cocrystal with an enhanced solubility and bioavailability.
Srivastava D; Fatima Z; Kaur CD; Mishra A; Nashik SS; Rizvi DA; Prasad R
Drug Dev Ind Pharm; 2022 Aug; 48(8):417-424. PubMed ID: 36073946
[TBL] [Abstract][Full Text] [Related]
8. Azilsartan-nicotinamide cocrystal: Preparation, characterization and in vitro / vivo evaluation.
Xiao Y; Jin T; Geng X; Zhu X
Eur J Pharm Sci; 2022 Sep; 176():106241. PubMed ID: 35716990
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis, characterization and antitumor activity of 5-fluorouracil-nicotinamide cocrystal].
Min WU; Xingang L; Yu X; Qi C; Xiurong HU; Jun Z; Guping T
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 46(2):127-133. PubMed ID: 28752703
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals.
Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K
Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850
[TBL] [Abstract][Full Text] [Related]
12. Curcumin and n-acetylcysteine cocrystal produced with supercritical solvent: characterization, solubility, and preclinical evaluation of antinociceptive and anti-inflammatory activities.
Paulazzi AR; Alves BO; Zilli GAL; Dos Santos AE; Petry F; Soares KD; Danielli LJ; Pedroso J; Apel MA; Aguiar GPS; Siebel AM; Oliveira JV; Müller LG
Inflammopharmacology; 2022 Feb; 30(1):327-341. PubMed ID: 35006455
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Study on Transformation of Coamorphous Baicalein-Nicotinamide to Its Cocrystal Form.
Ding F; Cao W; Wang R; Wang N; Li A; Wei Y; Qian S; Zhang J; Gao Y; Pang Z
J Pharm Sci; 2023 Feb; 112(2):513-524. PubMed ID: 36150469
[TBL] [Abstract][Full Text] [Related]
14. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
15. Improved Solubility and Oral Absorption of Emodin-Nicotinamide Cocrystal Over Emodin with PVP as a Solubility Enhancer and Crystallization Inhibitor.
Ban E; An SH; Park B; Park M; Yoon NE; Jung BH; Kim A
J Pharm Sci; 2020 Dec; 109(12):3660-3667. PubMed ID: 32987091
[TBL] [Abstract][Full Text] [Related]
16. Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating.
Serrano DR; Walsh D; O'Connell P; Mugheirbi NA; Worku ZA; Bolas-Fernandez F; Galiana C; Dea-Ayuela MA; Healy AM
Eur J Pharm Biopharm; 2018 Mar; 124():13-27. PubMed ID: 29196273
[TBL] [Abstract][Full Text] [Related]
17. A new cocrystal of isoniazid-quercetin with hepatoprotective effect: The design, structure, and in vitro/in vivo performance evaluation.
Liu F; Wang LY; Yu MC; Li YT; Wu ZY; Yan CW
Eur J Pharm Sci; 2020 Mar; 144():105216. PubMed ID: 31945451
[TBL] [Abstract][Full Text] [Related]
18. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
Aitipamula S; Das S
Eur J Pharm Biopharm; 2020 Apr; 149():95-104. PubMed ID: 32035236
[TBL] [Abstract][Full Text] [Related]
19. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.
Chow SF; Chen M; Shi L; Chow AH; Sun CC
Pharm Res; 2012 Jul; 29(7):1854-65. PubMed ID: 22359146
[TBL] [Abstract][Full Text] [Related]
20. Novel pharmaceutical cocrystal of lenalidomide with nicotinamide: Structural design, evaluation, and thermal phase transition study.
Wang L; Yan Y; Zhang X; Zhou X
Int J Pharm; 2022 Feb; 613():121394. PubMed ID: 34933081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
